Chronic lymphocytic leukaemia and Rheumatoid arthritis

The association between chronic lymphocytic leukaemia and rheumatoid arthritis has been confirmed in some cases. Rheumatoid arthritis is a chronic autoimmune inflammatory disease characterized by erosive arthritis of the joints.
Chronic lymphocytic leukaemia is a clonal malignancy of lymphocytes, which is manifested by immunosuppression, bone marrow failure, and organ infiltration with neoplastic cells.

Showing all 7 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
1
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
2 mg
-80°C
09/2018
126,90 
view product
Max: 10
Min: 3
Step: 1
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
2 mg
-80°C
12/2018
126,90 
view product
Max: 10
Min: 3
Step: 1
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
2 mg
-80°C
02/2019
126,90 
view product
Max: 10
Min: 3
Step: 1
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
2 mg
-80°C
02/2019
126,90 
view product
Max: 10
Min: 3
Step: 1
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
2 mg
-80°C
08/2019
126,90 
view product
Max: 10
Min: 3
Step: 1
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
2 mg
-80°C
12/2019
126,90 
view product
Max: 10
Min: 3
Step: 1
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
2 mg
-80°C
07/2021
126,90 
view product
Max: 10
Min: 3
Step: 1

Not looking for Chronic lymphocytic leukaemia and Rheumatoid arthritis?

Search our therapeutic molecules product database